AMA Calls for Ban on Direct to Consumer Advertising of Prescription Drugs and Medical Devices #galapagos #pharma

Posted On Jul 10 2017 by

#pharmaceutical advertising # AMA News Room AMA Calls for Ban on Direct to Consumer Advertising of Prescription Drugs and Medical Devices For immediate release: Nov. 17, 2015 ATLANTA Responding to the billions of advertising dollars being spent to promote prescription products, physicians at the Interim Meeting of the American Medical Association (AMA) today adopted new policy aimed at driving solutions to make prescription drugs more affordable. Physicians cited concerns that a growing proliferation of ads is driving demand for expensive treatments despite the clinical effectiveness of less costly alternatives. Today s vote in support of an advertising ban reflects concerns …


Suir Pharma Ireland #pharmacy #companies

Posted On Jul 10 2017 by

#pharma manufacturer # Stada Production Ireland T/A Suir Pharma Ireland Welcome to Suir Pharma Ireland ​Suir Pharma is an Independent contract manufacturing company working with many established Pharmaceutical companies worldwide. Suir Pharma (Formerly a Stada AG manufacturing site) is well known as an established manufacturer of generic medicines for more than 40 years with the highest quality standards. We are currently supplying various markets in Europe and have been supplying the United States since 1988. Both the facilities and resources of our site strategically position Suir Pharma to provide a high quality and cost effective contract manufacturing solution to your …


Pharmaceutical industry fights California drug price measure – The Orange County Register #swiss #pharma

Posted On Jul 10 2017 by

#pharmaceutical companies in orange county # BY PAULINE BARTOLONE. KAISER HEALTH NEWS Drugmakers are waging a fierce campaign against a proposed California law that would require them to justify the costs of their treatments and disclose major price hikes. The bill has widespread support of health care providers, insurers, patients, labor and business groups. But the pharmaceutical industry is behind scathing social media messaging, warning that passage of the bill could lead to shortages of crucial drugs in some parts of the state. The industry is also applying other pressure to change the language of the bill. A state Assembly …


OC DA Charges Pharmaceutical Companies For – Knowingly Harming Public Health – CBS Los Angeles #pharmaceutical #recruitment #agencies

Posted On Jul 10 2017 by

#pharmaceutical companies in orange county # OC DA Charges Pharmaceutical Companies For Knowingly Harming Public Health SANTA ANA (CBSLA.com) — The makers of OxyContin, as well as other prescription drugs that are considered potentially dangerous and addictive, are the targets of Orange County District Attorney Anthony Rackauckas, who alleged they duped doctors into believing the benefits of time-released, semi-synthetic opioids outweighed the risks. As District Attorney, I have the task of protecting the people of Orange County against false advertising and unfair business practices in consumer protection cases, Rackauckas said in a Thursday statement. Rackauckas went on to explain the …


Background on Drug Advertising #pharma #licensing

Posted On Jul 10 2017 by

#pharmaceutical advertising # Background on Drug Advertising The Food and Drug Administration (FDA) protects public health by assuring the safety, effectiveness, and security of a wide range of products, including human prescription drugs. We also advance public health by helping people get the accurate, science-based information they need to use medicines appropriately and improve their health. We serve the public health and welfare in many ways. One way is overseeing the approval and marketing of prescription drugs. Our authority is based on a number of federal laws, including the Federal Food, Drug, and Cosmetic Act. Among other areas, this law …


Raptor Pharmaceutical (RPTP) Stock Slumps, Said to be Exploring Sale #sun #pharma #sikkim

Posted On Jul 10 2017 by

#raptor pharma # Raptor Pharmaceutical (RPTP) Stock Slumps, Said to be Exploring Sale NEW YORK (TheStreet ) — Shares of Raptor Pharmaceutical Corp. (RPTP ) are dipping by 5.85% to $5.47 on heavy trading volume Thursday afternoon, as the biopharmaceutical company is in talks with investment banks to hire a financial adviser to explore a possible sale, according to sources cited by Reuters after yesterday’s market close. The move may not lead to a sale, the sources added. JMP Securities upgraded the stock to “market outperform” from “market perform” and established a $9 price target following the report. A sale …


Arbor Pharmaceuticals #pharma #packaging #solutions

Posted On Jul 10 2017 by

#pharma companies in usa # Improving Lives by Advancing Medicine Arbor Pharmaceuticals is an Atlanta, Georgia based specialty pharmaceutical company which markets prescription products for the cardiovascular, hospital, neuroscience, and pediatric markets. Arbor also has several branded prescription products filed with the FDA and in late stage development. In addition, the company has multiple generic prescription products on the market, filed with the FDA, and in various stages of development. We believe that our strongest asset is our people and have hired industry veterans with pharmaceutical knowledge and experience across most therapeutic areas encompassing all stages of development, manufacturing and …


PharmTech Home #basf #pharma

Posted On Jul 10 2017 by

#pharma tech # PharmTech eBook Series Bioprocessing Sterile Manufacturing eBook Read feature articles on accelerated scale-up for vaccine production, standards for air cleanliness classification, aseptic filling advances, a flexible approach to cleanroom design, a science-driven approach for microbial control, removing genotoxic impurities, regulatory enforcement, drug shortages, and validation of single-use shipping systems. View E-Book PharmTech Supplements Outsourcing Resources August 2016 Supplement Read feature articles on the outsourcing industry, virtual pharma, aseptic manufacturing, supply-chain complexities, serialization, data integrity, stability testing, technology transfer, and CMO/CDMO investment trends. Industry News


Quality in Pharmaceutical Manufacturing #pharma #industry #trends

Posted On Jul 10 2017 by

#mylan pharma # Mylan Worldwide Mylan Quality Mylan applies one global quality standard across our facilities, and across our product line regardless of market. At Mylan, whether it s a medication for millions or for a handful of people our priorities are to meet or exceed industry standards. Because there s nothing generic about our standards. Our internal teams conduct reviews of all products, start to finish. No matter where in the world they are made. In fact, we championed a law that empowers the FDA to biennially inspect all manufacturing facilities around the world that supply the U.S. market. …


Mylan Pharmaceuticals Inc #swiss #pharma

Posted On Jul 10 2017 by

#mylan pharma # Mylan Pharmaceuticals Inc. Latest Drug Information Updates Troxyca ER Troxyca ER (oxycodone hydrochloride and naltrexone hydrochloride) is an extended-release, abuse-deterrent. Adlyxin Adlyxin (lixisenatide) is a once-daily prandial glucagon-like peptide-1 (GLP-1) receptor agonist indicated. Xiidra Xiidra (lifitegrast) is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the. Epclusa Epclusa (sofosbuvir and velpatasvir) is a nucleotide analog polymerase inhibitor and pan-genotypic NS5A. Byvalson Byvalson (nebivolol and valsartan) is a beta adrenergic blocker and an angiotensin II receptor blocker (ARB). Zinbryta Zinbryta (daclizumab) is an interleukin-2 receptor blocking antibody indicated for the treatment of relapsing. More. Was this page helpful? …